|
Quotes & Info
|
| NKE > SEC Filings for NKE > Form 8-K on 23-Nov-2009 | All Recent SEC Filings |
23-Nov-2009
Change in Directors or Principal Officers, Financial Statements and Exhibits
Effective November 19, 2009, the NIKE, Inc. (the "Company") Board of Directors appointed Dr. Phyllis M. Wise to serve as a Director of the Company.
Phyllis M. Wise, Ph.D., is Executive Vice President and Provost of the University of Washington, where she is also professor of physiology and biophysics, biology, and obstetrics and gynecology. She joined the University of Maryland School of Medicine as an assistant professor in 1976, was appointed associate professor in 1982, and professor in 1987. Dr. Wise was appointed a professor and chair of the department of physiology at the University of Kentucky in 1993, and was appointed dean of the division of biological sciences and distinguished professor of neurobiology at the University of California Davis in 2002. In 2005, she was appointed Vice President and Provost at the University of Washington, and was appointed Executive Vice President and Provost in 2007. Dr. Wise has a doctorate in zoology from the University of Michigan, has an honorary doctorate from Swarthmore College, and is an elected member of the Institute of Medicine.
There was no arrangement or understanding pursuant to which Dr. Wise was elected as a director, and there are no related party transactions between the Company and Dr. Wise. Dr. Wise will also serve on the Company's Corporate Responsibility Committee.
The Company issued a press release on November 19, 2009 announcing the appointment of Dr. Wise. The press release is attached hereto as Exhibit 99.1.
(d) Exhibits
The following exhibits are being furnished with this Current Report on Form 8-K:
Exhibit 99.1 Press Release dated November 19, 2009.
|
|